Table 2.
Effect of topical medication on corneal endothelial cell density (CECD).
% mean cell CECD change at 1 year to baseline (SD) | Number of patients | Citation | |
---|---|---|---|
Prostaglandin analogues | |||
Latanoprost | 0.3 (2.2) | 127 | [86] |
−2.3 | 18 | [87] | |
−3.2 (6 months) | 54 | [88] | |
−0.04 (3 months) | 146 | [85] | |
| |||
Carbonic anhydrase inhibitor | |||
Dorzolamide | No significant difference | [79] | |
0.2 | 7 | [78] | |
−3.6 (5.0) | 148 | [83] | |
| |||
Beta blocker | |||
Timolol | −4.5 (4.2) | 72 | [83] |
0.1 (1.8) | 126 | [86] | |
Betoxalol | −4.2 (3.6) | 78 | [83] |
| |||
Rho Kinase Inhibitor | |||
Netarsudil 0.02% | 0.6 (3 months) | 143 | [85] |
| |||
Combined therapy | |||
Latanoprost-timolol | 0 (2.5) | 126 | [86] |
Latanoprost-brinzolamide | −0.6 | 16 | [87] |
Netarsudil 0.02%/latanoprost | 0.6 (3 months) | 126 | [85] |